The Danish medical cannabis industry – six months on
The future looks bright for the Danish medical cannabis industry, but speaking to Rikke Jakobsen, CEO of Cannabis Denmark, there is still work to...
Wearable medical devices: explore the global overview
As digital technology becomes increasingly integrated into the practice of medical care, wearable medical devices are evolving both technologically and physically.
An estimated one in...
The evolving tapestry of cannabis regulation in Colombia
Colombia is synonymous with cannabis farming, but are there more challenges creating cannabis regulation than it would appear?
For Canada’s leading cannabis producers, Colombia has...
Malta: paving the way for cannabis research and development
Talking about the wider landscape of medicinal cannabis research and development in Malta, John Charles Ellul explains more.
John Charles Ellul serves as Advisor to...
The world of cloud-based services: storing health data in the cloud
Delving into the rapidly growing industry of cloud-based services, Paul De Raeve of the European Federation of Nurses Associations (EFN), gives us an insight...
Dr Raphael Mechoulam and his revolutionary cannabis research
Renowned for his breakthrough discovery of THC, Raphael Mechoulam delves into the world of cutting-edge cannabis research.
Dr Raphael Mechoulam: the chemist responsible for isolating...
Medical cannabis in Pennsylvania and across the US
Thomas Perko of the Medical Cannabis Society shares his thoughts on the challenges facing both patients and companies regarding medical cannabis in Pennsylvania.
The medical...
The AI tech bubble will burst if it can’t prove itself beyond hype
While digital health investment continues to gather pace, many health tech startups are failing to materialise into long lasting impact, here Roeland Pater of...
Cannabis flavonoid could help treat pancreatic cancer
A recent study has concluded that a non-cannabinoid, non-psychoactive cannabis flavonoid, FBL-03G, has the potential to treat pancreatic cancer.
The study, conducted by researchers with...
Lip augmentation: lip fillers are carving an attractive niche in the cosmetology industry
The cosmetology industry has developed an interesting niche, with the emergence of safer and effective procedures – is lip augmentation the next plastic surgery...
The absorption of CBD: does CBD oil have no future?
Every time we use CBD oil we throw away 90-95% of the CBD because it is not absorbed by the body. How long will...
SAFE Banking Act of 2019: will banking be accessible to cannabis companies in the...
Ashley Elsner, CEO of artery Inc., weighs in on the effectiveness of the proposed legislation for spurring US financial institutions to serve cannabis companies...
The fight for getting access to medical cannabis in the UK goes on
Despite changes to the law in 2018, efforts to secure access to medical cannabis in the UK continue. Here, Hannah Deacon, mother and advocate,...
The first and only quota granting the processing and export of psychoactive cannabis
medcann Colombia makes history, once again, obtaining the first and only quota granted by the Colombian government for the processing and export of psychoactive...
UK Tick-borne Lyme disease cases may be higher than thought
New cases of tick-borne Lyme disease in the UK may be three times higher than previous estimates suggest. The finding suggest that new cases...
Discover the joint venture to develop therapeutics targeting chronic inflammatory conditions
Therapeutics for chronic inflammatory conditions may come sooner than you think as Tetra Bio-Pharma announce joint venture with Thorne and Onegevity Health to form...
Welcome to Health Data Research UK – the national institute for health data science
Ever wondered how Health Data Research UK is uniting UK’s health data to drive innovation & improve public health? Learn more about the health...
More human CBD trials are needed to understand its health benefits
A new review on CBD research suggests that more human CBD trials are needed to help us understand the health benefits.
The boom in the...
New research could help develop ways to detect risk of Alzheimer’s
Researchers have recently discovered that people who carry a gene associated with a higher risk of Alzheimer’s disease find it more difficult accessing recently...
The combination of cannabis cultivation know-how and extensive pharmaceutical experience
The Flowr Corporation completes the acquisition of Holigen, with operations in Portugal and Australia, bringing together cannabis cultivation and pharmaceutical experience.
Vinay Tolia, Flowr’s Chief...